Boston, MA -- (SBWIRE) -- 09/11/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (WebMD Health Corp. (NASDAQ:WBMD), McDermott International (NYSE:MDR), LeapFrog Enterprises, Inc. (NYSE:LF), Novavax, Inc. (NASDAQ:NVAX)
WebMD Health Corp. (NASDAQ:WBMD) shares gained 1.03% to $33.46. The company on August 12 announced that its Board of Directors has appointed David J. Schlanger as Chief Executive Officer of WebMD and Steven L. Zatz, M.D. as its President. Mr. Schlanger has served as Interim CEO since May 2013 and in other senior roles at WebMD and its predecessor companies for more than ten years prior to that time. Dr. Zatz has been with WebMD and its predecessor companies for more than ten years, most recently as Executive Vice President, Professional Services of WebMD, where he was responsible for the Company's professional websites and services including its flagship site for healthcare professionals, Medscape.com.
Is WBMD A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
McDermott International (NYSE:MDR) shares decreased 0.65% to $7.61. Glancy Binkow & Goldberg LLP on August 30 announces that all purchasers of McDermott International, securities between November 6, 2012 and August 5, 2013, inclusive, have until October 15, 2013 to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of Texas.
Additionally, the announcement follows shareholder approval of the transaction at each of the Special Meetings of CECO and Met-Pro, respectively, on August 26, 2013. Following the close of the market on August 27, 2013, Met-Pro common shares ceased trading on the NYSE.
Is MDR A Good Buy After The Recent Price Movement? Find Out Here
LeapFrog Enterprises, Inc. (NYSE:LF) shares decreased 0.41% to $9.78. The company on August 28 is revolutionizing the toy category by offering two new innovative learning solutions that encourage learning as they play, and turns their parents' Apple mobile devices into the ultimate learning tools.
Additionally, the company, on August 1, announced financial results for the second quarter ended June 30, 2013. Second quarter 2013 net sales were $83.0 million, up 16% compared to $71.5 million last year. Net loss (GAAP) for the second quarter was $3.3 million, an improvement of 59% compared to $8.1 million a year ago. Net loss per basic and diluted share (GAAP) was $0.05, an improvement of $0.07, or 58%, compared to $0.12 a year ago.
How Should Investors Trade LF After The Recent Volatility? Get Free Report Here
Novavax, Inc. (NASDAQ:NVAX) shares closed at $3.36. The company on August 22 announced the number of shares tendered to it during the extended acceptance period for its recommended public offer to acquire all issued and outstanding shares and warrants of Isconova AB, which was first communicated on June 4, 2013, and which was extended to August 20, 2013.
Additionally, the company announced that Stanley C. Erck, President and Chief Executive Officer, will present at the 2013 Stifel Nicolaus Healthcare Conference on Thursday, September 12, 2013 at 9:45 a.m. ET in Boston, MA at the Four Seasons.
How Should Investors Trade NVAX After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)